ライフサイエンスコーパス: acid phosphatase

1 asein was then dephosphorylated using potato acid phosphatase.

2 oclasts was determined by tartrate-resistant acid phosphatase.

3 ase, NT5E, and to a lesser extent, prostatic acid phosphatase.

4 , TRAF6, cathepsin K, and tartrate-resistant acid phosphatase.

5 the nuclear entry of lipin 1, a phosphatidic acid phosphatase.

6 m of activated PMN by secreting at least one acid phosphatase.

7 Mlo like protein, protein kinases and purple acid phosphatase.

8 ng peptide fragment of the protein prostatic acid phosphatase.

9 alkaline phosphatase, or tartrate-resistant acid phosphatase.

10 hematoxylin and eosin or tartrate-resistant acid phosphatase.

11 ith hematoxylin-eosin and tartrate-resistant acid phosphatase.

12 stimulate T-cell immunity against prostatic acid phosphatase.

13 hese genes is PHO5, which encodes a secreted acid phosphatase.

14 strated by the underglycosylation of surface acid phosphatase.

15 cts, such as androgen receptor and prostatic acid phosphatase.

16 ologue, murine Kv3.1b, are both modulated by acid phosphatases.

17 uld successfully identify previously unknown acid phosphatases.

18 and Pfr-GAP, to describe the three groups of acid phosphatases.

19 identify a large number of formerly unknown acid phosphatases.

20 lso identified by these profiles as putative acid phosphatases.

21 as 10(-10)) to bacterial class A nonspecific acid phosphatases.

22 and is the prototype of class C nonspecific acid phosphatases.

23 hanistic similarity to iron-dependent purple acid phosphatases.

24 of the P substrate spectrum based on purple acid phosphatases.

25 ge disequilibrium block containing the ACP1 (acid phosphatase 1) gene, a gene whose expression is sig

26 amage-binding protein 2 (DDB2) and lysosomal acid phosphatase 2 (ACP2) genes.

27 e protein (VCIP), also known as phosphatidic acid phosphatase 2b (PAP2b), in a functional assay of an

28 growth factor (PDGF)-beta, and phosphatidic acid phosphatase 2b (PPAP2B).

29 ins in different tissues, led us to identify acid phosphatase 5 (ACP5) as a candidate for the enzyme

30 of target genes like cathepsin K (Ctsk) and acid phosphatase 5 (Acp5) during osteoclast differentiat

31 , cathepsin K (Cstk), and tartrate-resistant acid phosphatase 5 (TRAP) with receptor activator of NF-

32 d gene encoding calcitonin receptor (Calcr), acid phosphatase 5, tartrate resistant (Acp5), cathepsin

33 erine/threonine protein phosphatases, purple acid phosphatases, 5'-nucleotidase, and DNA repair enzym

34 vo bone resorption marker tartrate-resistant acid phosphatase 5b (TRACP 5b).

35 e phosphatase (B-ALP) and tartrate-resistant acid phosphatase 5b (TRAP-5b), and calcium and alveolar

36 d by an increase in serum Tartrate-resistant acid phosphatase 5b (TRAP5b) levels.

37 Even though tartrate-resistant acid phosphatase 5b was expressed, proteolytic activatio

38 -terminal propeptide, and tartrate-resistant acid phosphatase 5b were associated with higher odds of

39 I collagen) and TRACP-5b (tartrate-resistant acid phosphatase 5b).

40 N-terminal propeptide, or tartrate-resistant acid phosphatase 5b; these values corresponded to the up

41 evels of human OPG-Fc and tartrate-resistant acid phosphatase-5b (TRAP-5b) were measured throughout t

42 The N-terminal portion of the M. catarrhalis acid phosphatase A (MapA) was most similar (the BLAST pr

43 e developed the first MRI approach to detect acid phosphatase (AcP) enzymatic activity.

44 om PMN through expression of an unidentified acid phosphatase (ACP).

45 Hence, the acid phosphatases AcpA, AcpB, and AcpC do not contribute

46 hu S4 the pathogenic roles of three distinct acid phosphatases, AcpA, AcpB, and AcpC, that are most c

47 se-1-phosphate (G1P) adsorbed on goethite by acid phosphatase (AcPase) can be of the same order of ma

48 diates the transport of ESCP and the soluble acid phosphatase (AcPh) to the PVs.

49 of this study was to delete the four primary acid phosphatases (Acps) from Francisella novicida and e

50 nd tartrate-sensitive and tartrate-resistant acid phosphatase activities and influences the appearanc

51 and human macrophages, despite decreases in acid phosphatase activities by as much as 95%.

52 alcium release or uptake, tartrate-resistant acid phosphatase activity (marker for osteoclasts), alka

53 unrecognized link between tartrate-resistant acid phosphatase activity and interferon metabolism and

54 ucture, but resulted in complete loss of its acid phosphatase activity as well as its anti-insect act

55 Pae SurEalpha has optimal acid phosphatase activity at temperatures above 90 degre

56 ne in M. catarrhalis strain O35E reduced the acid phosphatase activity expressed by this organism, an

57 Acid phosphatase activity in the highly infectious intra

58 n Escherichia coli confirmed the presence of acid phosphatase activity in the MapA protein.

59 e acid phosphatase domain in MapA eliminated acid phosphatase activity in the recombinant MapA protei

60 es (PBL) and enhanced the respiratory burst, acid phosphatase activity, chemotactic activity, and gen

61 which contributes most of the F. tularensis acid phosphatase activity, is secreted into the culture

62 gene product accounts for a majority of the acid phosphatase activity.

63 n (DeltaABCH) resulted in a 90% reduction in acid phosphatase activity.

64 of an autotransporter protein that expresses acid phosphatase activity.

65 its defense function is correlated with its acid phosphatase activity.

66 assessed by staining for tartrate-resistant acid phosphatase activity.

67 cuolar H(+)-ATPase; TRAP, tartrate-resistant acid phosphatase; alphaMEM D10, minimal essential media,

68 tions and increased serum tartrate-resistant acid phosphatase and 25-hydroxyvitamin D concentrations

69 They express prostatic acid phosphatase and androgen receptors and require seve

70 (248-286) is a peptide fragment of prostatic acid phosphatase and has been reported to form amyloid f

71 L-specific genes, such as tartrate-resistant acid phosphatase and immunoreceptor OCL-associated recep

72 role of LdRab1 in the secretion of secretory acid phosphatase and Ldgp63 in Leishmania.

73 ecific differences in the activities of both acid phosphatase and nitrate reductase.

74 Tartrate-resistant acid phosphatase and osteocalcin were used to identify o

75 HAD1 is a functional HAD protein having both acid phosphatase and phytase activities, it showed littl

76 arley, we found that the dynamics with which acid phosphatase and protease activities changed were di

77 involved in phosphate acquisition (the Pho1 acid phosphatase and the phosphate transporter SPBC8E4.0

78 steoclasts that expressed tartrate-resistant acid phosphatase and were capable of resorption.

79 ntly related to the other types, (2) class C acid phosphatases and (3) generic acid phosphatases (GAP

80 105-kDa protein that has similarity to both acid phosphatases and autotransporters.

81 , 2, and 3 are Mg(2+)-dependent phosphatidic acid phosphatases and catalyze the penultimate step of t

82 Finally, the structures suggest that class B acid phosphatases and CCAPs share a common strategy for

83 lies, which include known pathogens, class C acid phosphatases and GAP proteins are found in a variet

84 tularensis and prototype of a superfamily of acid phosphatases and phospholipases C.

85 This architecture is unique among acid phosphatases and resembles that of alkaline phospha

86 roteinase 9, cathepsin K, tartrate-resistant acid phosphatase, and carbonic anhydrase II in bone marr

87 of the HCL markers CD25, tartrate-resistant acid phosphatase, and cyclin D1, smoothening of leukemic

88 resorption, detection of tartrate-resistant acid phosphatase, and determination of gene expression.

89 eceptors for AGEs (RAGE), tartrate-resistant acid phosphatase, and proliferating cell nuclear antigen

90 receptor for AGEs (RAGE), tartrate-resistant acid phosphatase, and proliferating cell nuclear antigen

91 At the community level, potential acid phosphatase (AP) activity of ECM fungal root tips f

92 Plants secrete acid phosphatases (APases) into the apoplastic space, wh

93 hate is removed from NMN in the periplasm by acid phosphatase (AphA), and the produced nicotinamide r

94 ogether, this body of evidence suggests that acid phosphatases are general regulatory partners of Sha

95 Bacterial acid phosphatases are thought to play a major role in th

96 d expression of tartrate-sensitive prostatic acid phosphatase as a broadly acting ectonucleotidase.

97 rmation was determined by tartrate resistant acid phosphatase assay.

98 n this study, we identified ACPT (testicular acid phosphatase) biallelic mutations causing non-syndro

99 ficantly inhibits the secretion of secretory acid phosphatase by Leishmania.

100 proteolytic peptide fragments from prostatic acid phosphatase can form amyloid fibrils termed SEVI (s

101 Histidine acid phosphatases catalyze the transfer of a phosphoryl

102 eceptor, but they express tartrate-resistant acid phosphatase, cathepsin K, and beta(3) integrin, sug

103 ted transcription factor, tartrate-resistant acid phosphatase, cathepsin K, and beta3 integrin.

104 P4 is also the prototype of class C acid phosphatases (CCAPs), which are nonspecific 5',3'-n

105 rophosphorylation was decreased in prostatic acid phosphatase cDNA-transfected stable subclones of C-

106 spho-monoesterase, i.e. a tartrate-resistant acid phosphatase (Cl MAcP) was also found to be up-expre

107 main fold similar to that of human prostatic acid phosphatase, consisting of an alpha/beta core domai

108 Pharmacological inactivation of acid phosphatases could potentially help in the treatmen

109 -growing cells by cellular form of prostatic acid phosphatase (cPAcP) expression, a negative growth r

110 Cellular prostatic acid phosphatase (cPAcP), an authentic tyrosine phosphat

111 Thus, the Francisella acid phosphatases cumulatively play an important role in

112 o measure and characterise the activities of acid phosphatase, cysteine protease and nitrate reductas

113 orters upon proteolytic cleavage, as well as acid phosphatase cytochemistry to identify which endocyt

114 ein tyrosine phosphatase, cellular prostatic acid phosphatase, decreased correspondingly in those cel

115 dAMP, and BPQ-dCMP adducts were confirmed by acid phosphatase dephosphorylation of the BPQ-nucleotide

116 FtHAP and human prostatic acid phosphatase differ in the orientation of the crucia

117 phosphatase was consistent with phosphatidic acid phosphatase domain containing 2 (PPAPDC2), an uncha

118 (H233A) in the predicted active site of the acid phosphatase domain in MapA eliminated acid phosphat

119 Here, we use simulations of purple acid phosphatase evolution to show that amino acid prope

120 nsgenic construct using a tartrate-resistant acid phosphatase exon 1C promoter to drive expression of

121 ic screen for mutations that de-repress Pho1 acid phosphatase expression in CTD-T4A cells.

122 the rhizosphere (as a result of citrate and acid phosphatase exudation) compared with maize roots.

123 lp understand the catalytic mechanism of the acid phosphatase family.

124 ologous dendritic cells expressing prostatic acid phosphatase (for prostate cancer) or with autologou

125 fs in known alkaline phosphatases and purple acid phosphatase from red kidney bean shows that most of

126 The histidine acid phosphatase from the category A pathogen Francisell

127 AcpA is a respiratory burst-inhibiting acid phosphatase from the Centers for Disease Control an

128 results, we cloned genes encoding candidate acid phosphatases from genomic DNA or recovered from met

129 2) class C acid phosphatases and (3) generic acid phosphatases (GAP).

130 infection (SEVI) originating from prostatic acid phosphatase greatly increase XMRV infections of pri

131 e four Acps (AcpA, AcpB, AcpC, and histidine acid phosphatase [Hap]) in an F. novicida strain (DeltaA

132 ssed by histomorphometry, tartrate-resistant acid phosphatase histoenzymology, and cathepsin B (CATB)

133 ssed by histomorphometry, tartrate-resistant acid phosphatase histoenzymology, beta-galactosidase, sc

134 uencing of ACP5, encoding tartrate-resistant acid phosphatase, identified biallelic mutations in each

135 ar factor kappa beta, and tartrate-resistant acid phosphatase immunostaining.

136 volution of a phosphate starvation-inducible acid phosphatase in C. glabrata relative to most yeast s

137 o-terminal propeptide and tartrate-resistant acid phosphatase in KO mice confirmed reduced bone remod

138 the unexpected mitotic induction of the PHO5 acid phosphatase in rich medium requires the transcripti

139 In the acid phosphatase inducible PHO5 gene, we find that there

140 Lipin-1 is a Mg(2+)-dependent phosphatidic acid phosphatase involved in the de novo synthesis of ph

141 des a class of Mg(2+)-dependent phosphatidic acid phosphatases involved in the de novo synthesis of p

142 trolled activation of hydrolytic activity of acid phosphatase is successfully demonstrated.

143 se (TMPase, also known as fluoride-resistant acid phosphatase) is a classic histochemical marker of s

144 n phosphate transporter (LaPT1) and secreted acid phosphatase (LaSAP1) promoter-reporter genes when t

145 body mass index, race, Gleason score, stage, acid phosphatase level, prostatectomy history, and nodal

146 Mutants lacking either the known secreted acid phosphatases, lipases, phospholipase C, lysophospho

147 activator of the ER-associated phosphatidic acid phosphatase lipin that promotes synthesis of major

148 d dephosphorylates the mammalian phospatidic acid phosphatase, lipin.

149 d reactive substances, acetylcholinesterase, acid phosphatase), no significant effects were detected.

150 that inactivation of Ned1, the phosphatidic acid phosphatase of the lipin family, by CDK phosphoryla

151 results and on sequence alignment to purple acid phosphatases of known structure.

152 orphology was analyzed in tartrate-resistant acid phosphatase or F-actin-stained samples, and bone re

153 1b, the osteoclast marker tartrate-resistant acid phosphatase, or carbonic anhydrase II.

154 Human prostatic acid phosphatase (PAcP) is a prostate epithelium-specifi

155 regulated by the cellular form of prostatic acid phosphatase (PAcP), a prostate-unique protein tyros

156 absent on vacuoles lacking the phosphatidic acid phosphatase Pah1, which also lack Ypt7, the phospha

157 ined much less Mg(2+)-dependent phosphatidic acid phosphatase (PAP) activity than tissues from wild t

158 unized with a DNA vaccine encoding prostatic acid phosphatase (PAP) and a trans-vivo delayed-type hyp

159 Prostatic acid phosphatase (PAP) and ecto-5'-nucleotidase (NT5E) h

160 nts of the abundant semen proteins prostatic acid phosphatase (PAP) and semenogelins form amyloid fib

161 and Ingenuity Systems) identified prostatic acid phosphatase (PAP) as an enzyme overexpressed in pro

162 LPIN1, which encodes lipin-1, a phosphatidic acid phosphatase (PAP) controlling the rate-limiting ste

163 The lipin phosphatidic acid phosphatase (PAP) enzymes are required for triacylg

164 pins (lipin 1, 2, and 3) act as phosphatidic acid phosphatase (PAP) enzymes, which are required for t

165 enotype was caused by activation of a purple acid phosphatase (PAP) gene, AtPAP15, which contains a d

166 e X-ray crystal structure of human prostatic acid phosphatase (PAP) in complex with a phosphate ion h

167 ccine (pTVG-HP [MVI-816]) encoding prostatic acid phosphatase (PAP) in patients with recurrent, nonme

168 Prostatic acid phosphatase (PAP) is a prostate tumor antigen.

169 Prostatic acid phosphatase (PAP) is expressed in nociceptive dorsa

170 Lipin 2 is a phosphatidic acid phosphatase (PAP) responsible for the penultimate s

171 odology is able to report on human prostatic acid phosphatase (PAP), a tumor marker, with a limit of

172 al to the transmembrane isoform of prostatic acid phosphatase (PAP), an enzyme with unknown molecular

173 ostate-specific antigen (PSA), and prostatic acid phosphatase (PAP), and is derived from the highly a

174 pain may be mediated by decreased prostatic acid phosphatase (PAP), as PAP levels are markedly reduc

175 tion and, as a Mg(2+)-dependent phosphatidic acid phosphatase (PAP), is a key enzyme in the biosynthe

176 using Sipuleucel-T, an autologous prostatic acid phosphatase (PAP)-loaded dendritic cell immunothera

177 to-5'-nucleotidase (NT5E, CD73) or prostatic acid phosphatase (PAP, ACPP).

178 HT-1, while its mammalian homolog, prostatic acid phosphatase (PAP; also known as ACPP-201) stably as

179 (a proteolytic cleavage product of prostatic acid phosphatase, PAP(248-286)).

180 Lipin/Pah phosphatidic acid phosphatases (PAPs) generate diacylglycerol to regu

181 PhoD is most closely related to purple acid phosphatases (PAPs) with both types of enzyme conta

182 gy to members of the phosphoglycerate mutase/acid phosphatase (PGM/AcP) family of enzymes, with resid

183 st the gene encoding a phosphate-repressible acid phosphatase (PHO5) present in many yeasts including

184 port studies on a native E. coli periplasmic acid phosphatase, phytase (AppA), which contains three c

185 Thus, Francisella acid phosphatases play a major role in intramacrophage s

186 TRAP (tartrate-resistant acid phosphatase)-positive osteoclasts appeared on day 2

187 tein, along with elevated tartrate-resistant acid phosphatase-positive (TRAP+) OCs and alveolar bone

188 in (IL)-1beta levels, and tartrate-resistant acid phosphatase-positive (TRAP+) osteoclast numbers wer

189 d with significantly more tartrate-resistant acid phosphatase-positive (TRAP+) osteoclasts.

190 pletion of PDGF-BB in the tartrate-resistant acid phosphatase-positive cell lineage show significantl

191 number of multinucleated tartrate-resistant acid phosphatase-positive cells along the alveolar bone

192 osteoclasts with reduced tartrate-resistant acid phosphatase-positive cells and dentine resorption c

193 logical identification of tartrate-resistant acid phosphatase-positive cells.

194 ly enhanced the number of tartrate-resistant acid phosphatase-positive multinuclear osteoclast-like c

195 by counting the number of tartrate-resistant acid phosphatase-positive multinucleated cells and measu

196 from pannus invasion, and tartrate-resistant acid phosphatase-positive multinucleated cells at sites

197 9, and the generation of tartrate-resistant acid phosphatase-positive multinucleated cells in both c

198 No tartrate-resistant acid phosphatase-positive multinucleated cells or resorp

199 n, forming multinucleated tartrate-resistant acid phosphatase-positive osteoclast-like cells.

200 ctivity was analyzed with tartrate-resistant acid phosphatase-positive osteoclasts and preosteoclasts

201 zed by reduced numbers of tartrate-resistant acid phosphatase-positive osteoclasts at the tumor-bone

202 teoblasts and diminished tartrate resistance acid phosphatase-positive osteoclasts in the defects.

203 The number of tartrate-resistant acid phosphatase-positive osteoclasts was significantly

204 ssed for the abundance of Tartrate Resistant Acid Phosphatase-positive osteoclasts, which revealed th

205 videnced by a decrease in tartrate-resistant acid phosphatase-positive osteoclasts.

206 e marrow macrophages into tartrate-resistant acid phosphatase-positive preosteoclasts in culture but

207 nished formation of TRAP (tartrate-resistant acid phosphatase-positive) multinucleated osteoclasts, a

208 ibited reduced numbers of tartrate-resistant acid-phosphatase-positive cells and more proliferating c

209 bitory compounds for three of the four major acid phosphatases produced by F. tularensis SCHU4: AcpA,

210 d vaccines such as those targeting prostatic acid phosphatase, prostate-specific antigen, and cellula

211 hosphatase enzymes that also includes purple acid phosphatases, protein phosphatases, and nucleotide

212 Tartrate-resistant acid phosphatase reaction and immunohistochemical staini

213 Conversely, the rhizosphere soil acid phosphatase (RS-APase) activity was significantly h

214 However, rigorous demonstration of acid phosphatase secretion by intracellular Francisella

215 3.1.3.2), a periplasmic class B nonspecific acid phosphatase, significantly increased activity in pa

216 own to deposphorylate the yeast phosphatidic acid phosphatase Smp2p, and we show that Dullard dephosp

217 A parallel series of tartrate resistant acid phosphatase-stained sections were evaluated for ost

218 teoclasts were counted in tartrate-resistant acid phosphatase-stained sections.

219 teoclasts were counted on tartrate-resistant acid phosphatase-stained slides.

220 hematoxylin and eosin and tartrate-resistant acid phosphatase staining (TRAP).

221 assessed via quantitative tartrate-resistant acid phosphatase staining and degradation of human bone

222 Tartrate-resistant acid phosphatase staining demonstrated a marked decrease

223 ere expressed widely, and tartrate-resistant acid phosphatase staining notably was absent in the suba

224 On the basis of lysosomal acid phosphatase staining of infected macrophages and A.

225 tomography analysis, and tartrate-resistant acid phosphatase staining revealed reduced trabecular bo

226 Tartrate-resistant acid phosphatase staining showed that exposure to S100A9

227 Tartrate-resistant acid phosphatase staining was used to identify multinucl

228 with varying intensity of tartrate-resistant acid phosphatase staining were regularly present.

229 H&E and tartrate-resistant acid phosphatase staining were used to characterize and

230 tic cells was assessed by tartrate-resistant acid phosphatase staining, whereas the secretion of matr

231 phages were determined by tartrate-resistant acid phosphatase staining.

232 clasts were enumerated by tartrate-resistant acid phosphatase staining.

233 ells was determined after tartrate-resistant acid phosphatase staining.

234 n to OCs was confirmed by tartrate-resistant acid phosphatase staining; bone resorbing activity was a

235 n maize but greater exudation of citrate and acid phosphatase, suggesting a greater capacity to mobil

236 sella spp. is a respiratory-burst-inhibiting acid phosphatase that also exhibits phospholipase C acti

237 rancisella tularensis contains four putative acid phosphatases that are conserved in Francisella novi

238 nt ectonucleotidase, transmembrane prostatic acid phosphatase (TMPAP), in the SSFP region.

239 hematoxylin and eosin and tartrate-resistant acid phosphatase to confirm the presence of osteolytic b

240 This is the first evidence of acid phosphatase translocation during macrophage infecti

241 However, the absence of tartrate-resistant acid phosphatase (TRAP) activity and the lack of F4/80-p

242 inuclear cells expressing tartrate-resistant acid phosphatase (TRAP) activity produced by RANK-L-stim

243 of osteoclastogenesis and tartrate-resistant acid phosphatase (TRAP) activity was evaluated in RANKL-

244 e larger, fail to express tartrate-resistant acid phosphatase (TRAP) activity, and display a propensi

245 gnificantly reduced femur tartrate resistant acid phosphatase (TRAP) activity, suggesting potential r

246 rin-dependent 1 (NFATc1), tartrate-resistant acid phosphatase (TRAP) and cathepsin K in vitro.

247 mber of cells stained for tartrate-resistant acid phosphatase (TRAP) and immunohistochemical staining

248 dia and cell lysates, and tartrate-resistant acid phosphatase (TRAP) and mRNA detection for the osteo

249 ase (AP) for osteoblasts; tartrate-resistant acid phosphatase (TRAP) for osteoclasts; and the mineral

250 , plays a pivotal role in tartrate-resistant acid phosphatase (TRAP) gene expression.

251 gulated by the osteoclast tartrate-resistant acid phosphatase (TRAP) gene promoter (Tg/NCD).

252 ously to the proximal region of the tartrate acid phosphatase (TRAP) gene promoter and suppresses nuc

253 ), osteocalcin (OCN), and tartrate-resistant acid phosphatase (TRAP) immunohistochemical staining wer

254 n-regulates expression of tartrate-resistant acid phosphatase (TRAP) in mature osteoclasts.

255 The tartrate-resistant acid phosphatase (TRAP) is present in multiple tissues,

256 osin and subjected to the tartrate-resistant acid phosphatase (TRAP) method.

257 Tartrate-resistant acid phosphatase (TRAP) plays an important role in bone

258 membranes as indicated by tartrate-resistant acid phosphatase (TRAP) staining and pit formation.

259 munohistochemistry, using tartrate-resistant acid phosphatase (TRAP) staining to identify osteoclasts

260 Tartrate-resistant acid phosphatase (TRAP) staining, resorption pit assays,

261 number was determined by tartrate-resistant acid phosphatase (TRAP) staining.

262 istochemical detection of tartrate-resistant acid phosphatase (TRAP) were also performed.

263 steoprotegerin (OPG), and tartrate-resistant acid phosphatase (TRAP) were assessed.

264 formation of multinuclear tartrate-resistant acid phosphatase (TRAP)(+) osteoclasts, associated with

265 ), osteoprotegerin (OPG), tartrate-resistant acid phosphatase (TRAP), and activated caspase-3 were pe

266 NK-kappaB ligand (RANKL), tartrate-resistant acid phosphatase (TRAP), and osteoclast-associated recep

267 opeptidase 13 (MMP13) and tartrate-resistant acid phosphatase (TRAP), leading to an acceleration in p

268 ere fixed and stained for tartrate-resistant acid phosphatase (TRAP), Oregon Green 488-phalloidin, a

269 A, the positive cells for tartrate-resistant acid phosphatase (TRAP), receptor activator of nuclear f

270 ion of the active form of tartrate-resistant acid phosphatase (TRAP)-5b.

271 etected the appearance of tartrate-resistant acid phosphatase (TRAP)-negative multinucleated giant (M

272 vel of bone loss and less tartrate-resistant acid phosphatase (TRAP)-positive cell induction than M0

273 ased bone mass, increased tartrate-resistant acid phosphatase (TRAP)-positive cell number, and enhanc

274 rmation of multinucleated tartrate-resistant acid phosphatase (TRAP)-positive cells from primary muri

275 e loss in mice with fewer tartrate-resistant acid phosphatase (TRAP)-positive cells in alveolar bone.

276 ment cells displayed more tartrate-resistant acid phosphatase (TRAP)-positive cells than the co-cultu

277 Tartrate-resistant acid phosphatase (TRAP)-positive osteoclasts in the alve

278 er of osteoclasts by tartrate-acid resistant acid phosphatase (TRAP)-positivity.

279 , immunohistochemical, or tartrate-resistant acid phosphatase (TRAP)-stained sections.

280 lars until 6 months using tartrate resistant acid phosphatase (TRAP).

281 steoprotegerin (OPG), and tartrate-resistant acid phosphatase (TRAP).

282 numbers of multinucleated tartrate-resistant acid phosphatase (TRAP)/cathepsin K(+) OCs expressing ph

283 The enzyme tartrate resistant acid phosphatase (TRAP, two isoforms 5a and 5b) is highl

284 ], osteocalcin [OCN], and tartrate-resistant acid phosphatase [TRAP]) analyses were performed.

285 etry and immunohistology (Tartrate-Resistant Acid Phosphatase-TRAP, Osteocalcin and human specific an

286 , and a decrease in serum tartrate-resistant acid phosphatase (TRAP5b) concentration.

287 PhosPhatidic Acid Phosphatase type 2B (PPAP2B), an integral membrane

288 d, cathepsin K, and serum tartrate-resistant acid phosphatase type 5b, but ankle loading reduced oste

289 ed the LPA-degrading enzyme lysophosphatidic acid phosphatase type 6 (ACP6), leading to upregulation

290 based on rhamnulose-1-phosphate aldolase and acid phosphatase using racemic glyceraldehyde and dihydr

291 with ECM fungal richness and abundance, and acid phosphatase was correlated with nonECM fungal abund

292 alysis of more than 4000 annotated bacterial acid phosphatases was carried out.

293 kappaB ligand (RANKL) and tartrate resistant acid phosphatase were significantly diminished in CIA-ch

294 lthough levels of type 5b tartrate-resistant acid phosphatase were significantly lower than those obs

295 broad range, phosphate starvation-regulated acid phosphatase, which functionally replaces PHO5 in th

296 F. tularensis subspecies encode a series of acid phosphatases, which have been reported to play impo

297 into the following three types: (1) class B acid phosphatases, which were distantly related to the o

298 Francisella spp. encode a variety of acid phosphatases, whose roles in phagosomal escape and

299 An AppA homolog, Agp, a periplasmic acid phosphatase with similar structure, lacks the nonco

300 Lipins are phosphatidic acid phosphatases with a pivotal role in regulation of t